These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21164056)

  • 1. Propoxyphene withdrawal not a crisis, pharmacists say.
    Traynor K
    Am J Health Syst Pharm; 2011 Jan; 68(1):6,8. PubMed ID: 21164056
    [No Abstract]   [Full Text] [Related]  

  • 2. Trials and tribulations in the removal of dextropropoxyphene from the Australian Register of Therapeutic Goods.
    Buckley NA; Faunce TA
    Med J Aust; 2013 Aug; 199(4):257-60. PubMed ID: 23984782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food and Drug Administration recommends against the continued use of propoxyphene.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2011; 25(1):80-2. PubMed ID: 21426228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of propoxyphene withdrawal on opioid use in veterans.
    Hayes CJ; Hudson TJ; Phillips MM; Bursac Z; Williams JS; Austin MA; Edlund MJ; Martin BC
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1180-8. PubMed ID: 26248742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diplopia with dextropropoxyphene withdrawal.
    Mattoo SK; Mahajan S; Nebhinani N; Phuljhele S
    Gen Hosp Psychiatry; 2013; 35(1):100-1. PubMed ID: 23200698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Propoxyphene Market Withdrawal: Analgesic Substitutes, Doses, and Adverse Events.
    Jeffery MM; Morden NE; Larochelle M; Shah ND; Hooten WM; Meara E
    Med Care; 2020 Jan; 58(1):4-12. PubMed ID: 31651743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions for propoxyphene; Macrobid versus Macrodantin.
    DeDea L
    JAAPA; 2011 Feb; 24(2):16. PubMed ID: 21387964
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal poisonings involving propoxyphene before and after voluntary withdrawal from the United States' market: An analysis from the state of Florida.
    Delcher C; Chen G; Wang Y; Slavova S; Goldberger BA
    Forensic Sci Int; 2017 Nov; 280():228-232. PubMed ID: 29080523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.
    Puet B; DePriest A; Knight J; Heltsley R; Black DL; Caplan YH; Cone EJ
    J Anal Toxicol; 2013; 37(1):1-4. PubMed ID: 23129731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trend analysis of laboratory positive propoxyphene workplace urine drug screens before and after the product recall.
    Price J
    J Addict Med; 2015; 9(2):136-8. PubMed ID: 25622125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal outcome of a propoxyphene/acetaminophen (Darvocet) overdose: should it still be used in the United States?
    Jang DH; Hoffman RS; Nelson LS; Chu J; Bhanot K; Bagley W
    Ann Emerg Med; 2011 Apr; 57(4):421-2. PubMed ID: 21453827
    [No Abstract]   [Full Text] [Related]  

  • 12. Close vote by FDA advisers favors propoxyphene withdrawal.
    Traynor K
    Am J Health Syst Pharm; 2009 Mar; 66(6):518-20. PubMed ID: 19265176
    [No Abstract]   [Full Text] [Related]  

  • 13. Overdose risk prompts UK withdrawal of propoxyphene combination.
    Committee on the Safety of Medicines of the UK
    J Pain Palliat Care Pharmacother; 2006; 20(4):49-50. PubMed ID: 17182507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propoxyphene: an example of the need for increased pharmacist/patient interaction.
    Kennedy DL; Burke LB
    Am Pharm; 1979 Sep; 19(10):45-6. PubMed ID: 539538
    [No Abstract]   [Full Text] [Related]  

  • 15. Propoxyphene: is it a hazard to health?
    Ballin JC
    JAMA; 1979 Apr; 241(15):1618. PubMed ID: 430717
    [No Abstract]   [Full Text] [Related]  

  • 16. New warning on propoxyphene.
    FDA Drug Bull; 1979 Sep; 9(4):22-3. PubMed ID: 488581
    [No Abstract]   [Full Text] [Related]  

  • 17. Propoxyphene dependence and withdrawal.
    Strode SW
    Am Fam Physician; 1985 Sep; 32(3):105-8. PubMed ID: 4036770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propoxyphene and acetaminophen. Possible effects on the fetus.
    Golden NL; King KC; Sokol RJ
    Clin Pediatr (Phila); 1982 Dec; 21(12):752-4. PubMed ID: 6890421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is time to remove propoxyphene from clinical practice.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2009; 23(2):104-5. PubMed ID: 19492210
    [No Abstract]   [Full Text] [Related]  

  • 20. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
    Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
    JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.